爾茨海默病概念本周升溫,禮來(lái)阿爾茨海默病創(chuàng)新藥多納單抗(Donanemab)獲關(guān)注。 本周,A股阿爾茨海默病概念指數(shù)累計(jì)上漲近3%,其中11月8日該概念單日大漲2.53%。個(gè)股方面,北陸藥業(yè)
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net loss of 4.2 million
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 5 million
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net loss of 4.6 million
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 10.2
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 42.2
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 34.3
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 34.8
圖片
視頻
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net loss of 4.2 million
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net loss of 4.2 million
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 5 million
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net loss of 4.6 million
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 10.2
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 42.2
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 34.3
熱評(píng):
Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陸藥業(yè)股份有限公司) (300016.SZ) reported a net profit of 34.8
熱評(píng):